Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lars, Hvass"'
Autor:
Markus Staudt, Lars Hvass, Marius Müller, Rocío García-Vázquez, Jesper Tranekjær Jo̷rgensen, Vladimir Shalgunov, Umberto Maria Battisti, Andreas Kjær, Matthias M. Herth
Publikováno v:
ACS Omega, Vol 9, Iss 41, Pp 42498-42505 (2024)
Externí odkaz:
https://doaj.org/article/ebf0e50669e7435db03eabcbf74093f0
Autor:
Julie van Krimpen Mortensen, Simona Mattiussi, Lars Hvass, Emilie Graae Lund, Vladimir Shalgunov, Frank Roesch, Umberto Maria Battisti, Matthias Manfred Herth, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 14, Iss 18, p 2024 (2024)
The use of fibroblast activation protein inhibitors (FAPis) for positron emission tomography (PET) imaging in cancer has garnered significant interest in recent years, yielding promising results in preclinical and clinical settings. FAP is predominan
Externí odkaz:
https://doaj.org/article/0f620831dd6c421fb00297db7f050fe5
Autor:
Rocío García-Vázquez, Jesper Tranekjær Jørgensen, Klas Erik Bratteby, Vladimir Shalgunov, Lars Hvass, Matthias M. Herth, Andreas Kjær, Umberto Maria Battisti
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 245 (2022)
Pretargeted PET imaging is an emerging and fast-developing method to monitor immuno-oncology strategies. Currently, tetrazine ligation is considered the most promising bioorthogonal reaction for pretargeting in vivo. Recently, we have developed a met
Externí odkaz:
https://doaj.org/article/2326c356319e40338b7af8630b691a7e
Autor:
Natasha Bidesi, Vladimir Shalgunov, Umberto Maria Battisti, Lars Hvass, Jesper Tranekjær Jørgensen, Christian B. M. Poulie, Andreas I. Jensen, Andreas Kjaer, Matthias M. Herth
Publikováno v:
Bidesi, N, Shalgunov, V, Battisti, U M, Hvass, L, Jørgensen, J T, Poulie, C B M, Jensen, A I, Kjaer, A & Herth, M M 2023, ' Synthesis and radiolabeling of a polar [ 125 I]I-1,2,4,5-tetrazine ', Journal of Labelled Compounds and Radiopharmaceuticals, vol. 66, no. 1, pp. 22-30 . https://doi.org/10.1002/jlcr.4009
Pretargeting imaging has gained a lot of prominence, due to its excellent bioorthogonality and improved imaging contrast compared to conventional imaging. A new iodo tetrazine (Tz) derivative has been synthesized and further developed into the corres
Autor:
Marius, Müller, Vladimir, Shalgunov, Lars, Hvass, Jesper T, Jørgensen, Vasko, Kramer, Markus, Staudt, Umberto Maria, Battisti, Andreas, Kjaer, Matthias M, Herth
Publikováno v:
Bioorganicmedicinal chemistry letters. 80
Tucatinib is a selective human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor approved by the U.S. Food and Drug Administration (FDA) in April 2020 for HER2-positive lesions in metastatic breast cancer patients, including CNS met
Autor:
François Crestey, Andreas Kjaer, Jesper L. Kristensen, Ida Nymann Petersen, Daniel L. Stares, Umberto Maria Battisti, Vladimir Shalgunov, Hannes Mikula, Dennis Svatunek, Matthias M. Herth, Andreas Löffler, Jesper Tranekjær Jørgensen, Lars Hvass, Rocío García-Vázquez
Publikováno v:
García-Vázquez, R, Battisti, U M, Jørgensen, J T, Shalgunov, V, Hvass, L, Stares, D L, Petersen, I N, Crestey, F, Löffler, A, Svatunek, D, Kristensen, J L, Mikula, H & Herth, M M 2021, ' Direct Cu-mediated aromatic 18 F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging. ', Chemical Science, vol. 12, no. 35, pp. 11668-11675 . https://doi.org/10.1039/d1sc02789a
Chemical Science
García-Vázquez, R, Battisti, U M, Jørgensen, J T, Shalgunov, V, Hvass, L, Stares, D L, Petersen, I N, Crestey, F, Löffler, A, Svatunek, D, Kristensen, J L, Mikula, H, Kjaer, A & Herth, M M 2021, ' Direct Cu-mediated aromatic 18 F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging ', Chemical Science, vol. 12, no. 35, pp. 11668-11675 . https://doi.org/10.1039/d1sc02789a
Chemical Science
García-Vázquez, R, Battisti, U M, Jørgensen, J T, Shalgunov, V, Hvass, L, Stares, D L, Petersen, I N, Crestey, F, Löffler, A, Svatunek, D, Kristensen, J L, Mikula, H, Kjaer, A & Herth, M M 2021, ' Direct Cu-mediated aromatic 18 F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging ', Chemical Science, vol. 12, no. 35, pp. 11668-11675 . https://doi.org/10.1039/d1sc02789a
Pretargeted imaging can be used to visualize and quantify slow-accumulating targeting vectors with short-lived radionuclides such as fluorine-18 – the most popular clinically applied Positron Emission Tomography (PET) radionuclide. Pretargeting res
Autor:
Rocío, García-Vázquez, Jesper Tranekjær, Jørgensen, Klas Erik, Bratteby, Vladimir, Shalgunov, Lars, Hvass, Matthias M, Herth, Andreas, Kjær, Umberto Maria, Battisti
Publikováno v:
Pharmaceuticals (Basel, Switzerland). 15(2)
Pretargeted PET imaging is an emerging and fast-developing method to monitor immuno-oncology strategies. Currently, tetrazine ligation is considered the most promising bioorthogonal reaction for pretargeting in vivo. Recently, we have developed a met
Autor:
Marius Müller, Vladimir Shalgunov, Lars Hvass, Jesper T. Jørgensen, Vasko Kramer, Markus Staudt, Umberto Maria Battisti, Andreas Kjaer, Matthias M. Herth
Publikováno v:
Müller, M, Shalgunov, V, Hvass, L, Jørgensen, J T, Kramer, V, Staudt, M, Battisti, U M, Kjaer, A & Herth, M M 2023, ' Synthesis and in vivo evaluation of [ 11 C]tucatinib for HER2-targeted PET imaging ', Bioorganic and Medicinal Chemistry Letters, vol. 80, 129088 . https://doi.org/10.1016/j.bmcl.2022.129088
Tucatinib is a selective human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor approved by the U.S. Food and Drug Administration (FDA) in April 2020 for HER2-positive lesions in metastatic breast cancer patients, including CNS met
Autor:
Rocío García Vázquez, Umberto Battisti, Jesper Jørgensen, Vladimir Shalgunov, Christian Poulie, Lars Hvass, Ida Petersen, Dennis Svatunek, Jesper Kristensen, Hannes Mikula, Andreas Jensen, Sture Lindegren, Holger Jensen, Andreas Kjær, Matthias Herth
Publikováno v:
Nuclear Medicine and Biology. :S55-S56
Autor:
Klas Bratteby, Umberto Battisti, Rocío García Vázquez, Vladimir Shalgunov, Jesper Jørgensen, Lars Hvass, Sara Lopes van den Broek, Ida Petersen, Maria Erlandsson, Tomas Ohlsson, Nic Gillings, Hannes Mikula, Andreas Kjær, Matthias Herth
Publikováno v:
Nuclear Medicine and Biology. :S79-S80